Raymond James Financial’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.6K Hold
30,758
– – ﹤0.01% 5185
2026
Q1
$74.4K Hold
30,758
– – ﹤0.01% 5083
2025
Q4
$134K Hold
30,758
– – ﹤0.01% 4873
2025
Q3
$129K Buy
30,758
+1,825
+6% +$6.48K ﹤0.01% 4705
2025
Q2
$83K Buy
28,933
+5,333
+23% +$14.1K ﹤0.01% 4955
2025
Q1
$63.7K Buy
23,600
+6,350
+37% +$23.8K ﹤0.01% 4617
2024
Q4
$40.7K Buy
+17,250
New +$45.9K ﹤0.01% 4632

Other funds holding GNLX

Raymond James Financial's GNLX Position: Q2 2026 in Review

Raymond James Financial held its Genelux (GNLX) position steady in Q2 2026 at 30,758 shares worth $92.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5185.

Raymond James Financial first reported a position in GNLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $134K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Raymond James Financial held 30,758 shares of Genelux worth $92.6K as of Q2 2026.
  • Raymond James Financial left its Genelux share count unchanged in Q2 2026.
  • Genelux made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5185 holding.
  • Raymond James Financial first reported a position in Genelux in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Genelux position peaked at $134K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.